David Arend, MD
Urology · Sioux Falls, SDNPI 1548478118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in SD, where the typical reported total is $713.
Across 38 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$198
- Johnson & Johnson$152
- 180 Medical, Inc.$129
- Procept Biorobotics Corporation$125
- Sumitomo Pharma America, Inc.$60
- Pfizer$44
- plus $240 from 11 others
What the payments were for
- Food & beverage$93699%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $198 |
| Johnson & Johnson | 5 | $152 |
| 180 Medical, Inc. | 7 | $129 |
| Procept Biorobotics Corporation | 1 | $125 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Pfizer | 3 | $44 |
| AbbVie(2 entities) | 3 | $43 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $42 |
| EDAP Technomed Inc | 1 | $25 |
| KCI USA, Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Bayer | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Rochester Medical Corporation | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Urogen Pharma, Inc. | 1 | $12 |
| Progenics Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUABEAM SYSTEM$125
- ADVANCE$111
How this compares
$948 in reported general payments places this provider in the 50th percentile of 40 urology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 95 | $54,938 |
| GemtesaVibegron | 70 | $36,324 |
| Tamsulosin Hcl | 397 | $5,406 |
| Trimethoprim | 14 | $1,612 |
| Finasteride | 165 | $1,602 |
| Trospium Chloride | 17 | $1,253 |
| Methenamine Hippurate | 18 | $1,087 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 49 | $908 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $818 |
| Estradiol | 11 | $710 |
| NitrofurantoinNitrofurantoin Macrocrystal | 24 | $418 |
| Megestrol Acetate | 22 | $409 |
| Solifenacin Succinate | 20 | $343 |
| Amitriptyline Hcl | 39 | $323 |
| Cephalexin | 48 | $224 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $15 | $54,93895 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $60 | $36,32470 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 40 urology providers in South Dakota.
Other urology in Sioux Falls
- Lauren ThumSioux Falls$7K
- Eugene ParkSioux Falls$2K
- Nathan BockholtSioux Falls$2K
- Matthew WitteSioux Falls$2K
- Dennis ThumSioux Falls$2K
- Brian LindamanSioux Falls$1K
- Matthew LarsonSioux Falls$1K
- Darlys HoferSioux Falls$1K
- Michael GillettSioux Falls$713
- Alex HannemannSioux Falls$645
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.